Connection

Aldo Maggioni to Adult

Back to Details
This is a "connection" page, showing publications Aldo Maggioni has written about Adult.
Aldo Maggioni
Connection Strength
0.081
Adult
  1. Patterns of treatment with antiplatelet therapy after an acute coronary syndrome: Data from a large database in a community setting. Eur J Prev Cardiol. 2019 05; 26(8):836-846.
    View in: PubMed
    Score: 0.013
  2. [The REVEAL study]. G Ital Cardiol (Rome). 2018 Feb; 19(2):71-76.
    View in: PubMed
    Score: 0.012
  3. Use of lipid lowering drugs in patients at very high risk of cardiovascular events: An analysis on nearly 3,000,000 Italian subjects of the ARNO Observatory. Int J Cardiol. 2017 Nov 01; 246:62-67.
    View in: PubMed
    Score: 0.012
  4. Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy. Drugs Aging. 2020 12; 37(12):925-933.
    View in: PubMed
    Score: 0.004
  5. Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC). Eur Heart J. 2019 12 14; 40(47):3848-3855.
    View in: PubMed
    Score: 0.004
  6. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019 10 14; 40(39):3222-3232.
    View in: PubMed
    Score: 0.003
  7. Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry. Europace. 2019 07 01; 21(7):1013-1022.
    View in: PubMed
    Score: 0.003
  8. Target Population of Non-deferrable Surgery and Uncontrolled Severe Bleeding Related to Dabigatran. Cardiovasc Drugs Ther. 2018 06; 32(3):281-286.
    View in: PubMed
    Score: 0.003
  9. The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies. Eur Heart J. 2018 05 21; 39(20):1784-1793.
    View in: PubMed
    Score: 0.003
  10. Influence of socioeconomic factors on pregnancy outcome in women with structural heart disease. Heart. 2018 05; 104(9):745-752.
    View in: PubMed
    Score: 0.003
  11. Heart failure with reduced ejection fraction. Nat Rev Dis Primers. 2017 Aug 24; 3:17058.
    View in: PubMed
    Score: 0.003
  12. Declining Risk of Sudden Death in Heart Failure. N Engl J Med. 2017 07 06; 377(1):41-51.
    View in: PubMed
    Score: 0.003
  13. Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial. J Am Heart Assoc. 2017 Jul 05; 6(7).
    View in: PubMed
    Score: 0.003
  14. Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure. N Engl J Med. 2017 05 18; 376(20):1956-1964.
    View in: PubMed
    Score: 0.003
  15. Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM. Eur J Heart Fail. 2017 09; 19(9):1131-1141.
    View in: PubMed
    Score: 0.003
  16. European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology. Eur Heart J. 2016 Jan 07; 37(2):164-73.
    View in: PubMed
    Score: 0.003
  17. Cardiac medication during pregnancy, data from the ROPAC. Int J Cardiol. 2014 Nov 15; 177(1):124-8.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.